These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 20805445)

  • 1. What is the value of the 21-gene recurrence score?
    Brauchli P; Thürlimann B; Crowe SN; Herrmann R
    J Clin Oncol; 2010 Nov; 28(32):e671-2; author reply 673-4. PubMed ID: 20805445
    [No Abstract]   [Full Text] [Related]  

  • 2. Basal and triple-negative breast cancers: impact on clinical decision-making and novel therapeutic options.
    Voduc D; Nielsen TO
    Clin Breast Cancer; 2008 Dec; 8 Suppl 4():S171-8. PubMed ID: 19158038
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of the 21-gene assay and its application in clinical practice and clinical trials.
    Sparano JA; Paik S
    J Clin Oncol; 2008 Feb; 26(5):721-8. PubMed ID: 18258979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Gene expression profiling in lung cancer. Experimental research and clinical application].
    Kuner R; Hoffmann H; Sültmann H
    Dtsch Med Wochenschr; 2009 Mar; 134(11):519-21. PubMed ID: 19259908
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?
    Correa Geyer F; Reis-Filho JS
    Int J Surg Pathol; 2009 Aug; 17(4):285-302. PubMed ID: 19103611
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genomics centers. Disease gene research heats up in the desert.
    Jensen MN
    Science; 2002 Jul; 297(5578):29-30. PubMed ID: 12098677
    [No Abstract]   [Full Text] [Related]  

  • 7. Defining the clinical utility of gene expression assays in breast cancer: the intersection of science and art in clinical decision making.
    Sparano JA; Solin LJ
    J Clin Oncol; 2010 Apr; 28(10):1625-7. PubMed ID: 20065178
    [No Abstract]   [Full Text] [Related]  

  • 8. [The value of gene expression profiles using micoarrays for the individualisation of adjuvant therapy after surgery for breast cancer].
    Klijn JG; de Vries EG
    Ned Tijdschr Geneeskd; 2005 Mar; 149(12):618-22. PubMed ID: 15813427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cancer research. As questions grow, Duke halts trials, launches investigation.
    Couzin-Frankel J
    Science; 2010 Aug; 329(5992):614-5. PubMed ID: 20688986
    [No Abstract]   [Full Text] [Related]  

  • 10. Breast cancer gene microarrays pass muster.
    Twombly R
    J Natl Cancer Inst; 2006 Oct; 98(20):1438-40. PubMed ID: 17047189
    [No Abstract]   [Full Text] [Related]  

  • 11. Biliary tract cancers: molecular profiling as a tool for treatment decisions. A literature review.
    Berardi R; Scartozzi M; Freddari F; Squadroni M; Santinelli A; Bearzi I; Fabris G; Cascinu S
    Cancer Treat Rev; 2006 Aug; 32(5):333-47. PubMed ID: 16762510
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Process and content of decision making by advanced cancer patients.
    Bruera E
    J Clin Oncol; 2006 Mar; 24(7):1029-30. PubMed ID: 16505421
    [No Abstract]   [Full Text] [Related]  

  • 13. When will tumor gene expression profiling be incorporated into clinical breast cancer decision making?
    Creighton CJ; Rae JM
    Breast Cancer Res; 2006; 8(4):302. PubMed ID: 16834787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Should the FDA be the doctor of last resort?
    DeVita VT
    Nat Clin Pract Oncol; 2005 Sep; 2(9):423. PubMed ID: 16264991
    [No Abstract]   [Full Text] [Related]  

  • 15. Supportive therapies in the management of myeloma.
    Ludwig H;
    Oncology (Williston Park); 2004 Mar; 18(3):295-6, 298. PubMed ID: 15065700
    [No Abstract]   [Full Text] [Related]  

  • 16. Changing paradigms in breast cancer management: introducing molecular genetics into the treatment algorithm.
    Rayhanabad JA; Difronzo LA; Haigh PI; Romero L
    Am Surg; 2008 Oct; 74(10):887-90. PubMed ID: 18942607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Patient information--patients must make decision. Interview by Kirsten Bjørnsson].
    Astrup K
    Sygeplejersken; 1992 Nov; 92(46):18-9. PubMed ID: 1297217
    [No Abstract]   [Full Text] [Related]  

  • 18. Growth industry.
    Lewis R
    Nature; 2004 Mar; 428(6980):348-9. PubMed ID: 15029202
    [No Abstract]   [Full Text] [Related]  

  • 19. "Marking" of cancer: the road to clinical decision making.
    Sudoyo AW
    Acta Med Indones; 2010 Jan; 42(1):1. PubMed ID: 20737744
    [No Abstract]   [Full Text] [Related]  

  • 20. [Joint decision making, how? Physician-patient communication about palliative treatment].
    Tan MB
    Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2417-8. PubMed ID: 9554164
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.